Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Journal of Gastroenterology|January 28, 2015
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver diseaseYoshio Sumida, Kazuyuki Kanemasa, Shunsuke Imai, et al.
Plos One|June 22, 2012
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in JapaneseTakahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, et al.
Journal of Gastroenterology|November 3, 2010
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver diseaseYuichiro Eguchi, Toshihiko Mizuta, Yoshio Sumida, et al.
Hepatology (Baltimore, Md.)|December 24, 2021
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver diseaseNobuyoshi Kawamura, Kento Imajo, Kyle J Kalutkiewicz, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2014
Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinomaMasayasu Jo, Kohichiroh Yasui, Toshihiko Kirishima, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseYoshio Sumida, Masashi Yoneda, Yuya Seko, et al.
BMC Gastroenterology|August 10, 2017
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot studyYasushi Honda, Takaomi Kessoku, Yoshio Sumida, et al.
The American Journal of Medicine|May 2, 2025
Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-AnalysisDo Han Kim, Donghyun Ko, Pojsakorn Danpanichkul, et al.
Journal of Gastroenterology and Hepatology|January 23, 2019
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosisKazuhisa Kodama, Takumi Kawaguchi, Hideyuki Hyogo, et al.
European Radiology|December 5, 2024
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASHKento Imajo, Yusuke Saigusa, Takashi Kobayashi, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Journal of Gastroenterology|January 28, 2015
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver diseaseYoshio Sumida, Kazuyuki Kanemasa, Shunsuke Imai, et al.
Plos One|June 22, 2012
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in JapaneseTakahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, et al.
Journal of Gastroenterology|November 3, 2010
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver diseaseYuichiro Eguchi, Toshihiko Mizuta, Yoshio Sumida, et al.
Hepatology (Baltimore, Md.)|December 24, 2021
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver diseaseNobuyoshi Kawamura, Kento Imajo, Kyle J Kalutkiewicz, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2014
Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinomaMasayasu Jo, Kohichiroh Yasui, Toshihiko Kirishima, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseYoshio Sumida, Masashi Yoneda, Yuya Seko, et al.
BMC Gastroenterology|August 10, 2017
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot studyYasushi Honda, Takaomi Kessoku, Yoshio Sumida, et al.
The American Journal of Medicine|May 2, 2025
Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-AnalysisDo Han Kim, Donghyun Ko, Pojsakorn Danpanichkul, et al.
Journal of Gastroenterology and Hepatology|January 23, 2019
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosisKazuhisa Kodama, Takumi Kawaguchi, Hideyuki Hyogo, et al.
European Radiology|December 5, 2024
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASHKento Imajo, Yusuke Saigusa, Takashi Kobayashi, et al.
Pageof 22